Artiva Biotherapeutics (ARTV) Insider Trading & Ownership $12.53 -0.22 (-1.73%) (As of 11:47 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Artiva Biotherapeutics (NASDAQ:ARTV) Insider Buying and Selling ActivityNumber OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$30.00 MNumber OfInsiders Selling(Last 12 Months)0 Get ARTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Artiva Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ARTV Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Artiva Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/22/2024Global Strategic Fund I VenbioMajor ShareholderBuy416,666$12.00$4,999,992.00 7/22/2024Yong-Jun HuhDirectorBuy2,083,332$12.00$24,999,984.00 (Data available from 1/1/2013 forward) ARTV Insider Trading Activity - Frequently Asked Questions Who is on Artiva Biotherapeutics's Insider Roster? The list of insiders at Artiva Biotherapeutics includes Global Strategic Fund I Venbio, and Yong-Jun Huh. Learn more on insiders at ARTV. Which Artiva Biotherapeutics insiders have been buying company stock? The following insiders have purchased ARTV shares in the last 24 months: Global Strategic Fund I Venbio ($4,999,992.00), and Yong-Jun Huh ($24,999,984.00). How much insider buying is happening at Artiva Biotherapeutics? Insiders have purchased a total of 2,499,998 ARTV shares in the last 24 months for a total of $29,999,976.00 bought. Artiva Biotherapeutics Key ExecutivesDr. Fred Aslan M.D. (Age 49)President, CEO & Director Compensation: $917.3kDr. Peter Flynn Ph.D. (Age 50)Co-Founder & Strategic Advisor Compensation: $499.37kMs. Jennifer Kinsbruner Bush Esq. (Age 49)J.D., Executive VP, COO, Chief Legal Officer, Corporate Secretary & Compliance Officer Compensation: $630.31kMr. Christopher P. Horan (Age 57)Chief Technical Operations Officer Compensation: $612.23kMs. Neha Krishnamohan (Age 37)CFO & Executive VP of Corporate Development Dr. Thorsten Graef M.D. (Age 48)Ph.D., Chief Medical Officer Dr. Heather Raymon Ph.D. (Age 60)Senior Vice President of Research & Early Development Mr. Eugene HelselSenior Vice President of Regulatory AffairsDr. K. C Lim Pharm.D.Senior Vice President of Clinical Operations More Insider Trading Tools from MarketBeat Related Companies VIR Insider Trades LENZ Insider Trades ADPT Insider Trades REPL Insider Trades PSTX Insider Trades CRGX Insider Trades AVXL Insider Trades RLAY Insider Trades CGEM Insider Trades TECX Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NASDAQ:ARTV) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
